£107.61

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Price data last checked 81 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 10 days • 10 data points (No recent data available)

Historical
Generating forecast...
£107.61 £107.41 £107.46 £107.50 £107.54 £107.58 £107.63 08 April 2026 10 April 2026 12 April 2026 14 April 2026 17 April 2026

Price Distribution

Price distribution over 10 days • 1 price levels

Days at Price
10 days 0 3 5 8 10 £107 Days at Price

Price Analysis

Most common price: £107 (10 days, 100.0%)

Price range: £107 - £107

Price levels: 1 different prices over 10 days

Description

Traditional cancer treatments such as chemotherapy, radiation, and hormonal therapy often lack selectivity and can result in high toxicity. This volume explores the alternative approach of antibody-mediated anti-cancer therapy, which offers a more selective and less toxic method for treating various cancers. This book examines how monoclonal antibodies (mAbs) function to destroy malignant tumor cells and prevent growth by blocking specific cell receptors. It also addresses the potential for these therapies to reverse existing drug and radiation resistance. As part of the Resistance to Targeted Anti-Cancer Therapeutics series, this second volume provides essential knowledge for understanding how to overcome resistance in immunotherapeutic antibody treatments.

Key Features

Examines antibody-mediated anti-cancer therapy as a less toxic and more selective alternative to traditional chemotherapy and radiation.

Provides insight into how monoclonal antibodies (mAbs) work to destroy malignant tumor cells and block specific cell receptors.

Explores methods and strategies used to reverse drug and radiation resistance in cancer patients.

Part of the specialized Resistance to Targeted Anti-Cancer Therapeutics series for advanced medical study.

Focuses on the mechanisms of monoclonal antibodies to prevent tumor growth and target cancer cells specifically.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
05 August 2013
Listed Since
04 April 2013

Barcode

No barcode data available

Similar Products You Might Like

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
96% match

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Academic Press

£92.89 04 Jul 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
96% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£68.79 06 Mar 2026
Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation
96% match

Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation

Academic Press

£114.57 18 Apr 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
96% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 03 Jul 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
96% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£78.99 03 Jul 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
96% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£176.00 09 Apr 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
96% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)

Springer

£165.42 03 Jul 2026
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
96% match

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£68.52 08 Mar 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
96% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£89.34 03 Jul 2026
Basic Immunology: Functions and Disorders of the Immune System
96% match

Basic Immunology: Functions and Disorders of the Immune System

Elsevier

£51.39 16 Mar 2026
Humana Cancer Immunosurveillance: Methods and Protocols 1884
96% match

Humana Cancer Immunosurveillance: Methods and Protocols 1884

Humana

£104.04 18 Apr 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
96% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£110.83 07 Mar 2026
Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)
96% match

Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)

Humana

£74.87 08 Mar 2026
Humana Immune Receptors: Methods and Protocols 748 Book
96% match

Humana Immune Receptors: Methods and Protocols 748 Book

Humana

£100.81 14 Apr 2026
A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy
96% match

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Wiley

£41.65 18 Mar 2026
Advances in Immunology: 95: Volume 95
96% match

Advances in Immunology: 95: Volume 95

Academic Press

£109.97 10 Mar 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
96% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£94.01 09 Mar 2026
Advances in Immunology: 92: Volume 92
96% match

Advances in Immunology: 92: Volume 92

Academic Press

£109.97 06 Mar 2026
Advances in Immunology: v. 96: Volume 96
96% match

Advances in Immunology: v. 96: Volume 96

Academic Press

£109.99 11 Mar 2026
Advances in Immunology: Volume 149
96% match

Advances in Immunology: Volume 149

Academic Press

£132.49 01 Jul 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
96% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£188.36 08 Mar 2026